BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Van Tassell B, Mihalick V, Thomas G, Marawan A, Talasaz AH, Lu J, Kang L, Ladd A, Damonte JI, Dixon DL, Markley R, Turlington J, Federmann E, Del Buono MG, Biondi-Zoccai G, Canada JM, Arena R, Abbate A. Rationale and design of interleukin-1 blockade in recently decompensated heart failure (REDHART2): a randomized, double blind, placebo controlled, single center, phase 2 study. J Transl Med 2022;20:270. [PMID: 35706006 DOI: 10.1186/s12967-022-03466-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Mahfooz K, Rana A, Palagati K, Suvarna AK, Perryman C, Gaddipati SP, Adhnon A, Andani R, Vasavada A. Anakinra in Heart Failure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Med Sci (Basel) 2022;11. [PMID: 36649041 DOI: 10.3390/medsci11010004] [Reference Citation Analysis]
2 Souza Oliveira CV, Moreno-loaiza O, Figueiredo-vanzan D, Peroba Ramos I, Mata-santos H, Torres Bozza M, Neto Paiva C, Medei E. IL-1β is not critical to chronic heart dysfunction in mice with Chagas disease. Front Immunol 2022;13:1010257. [DOI: 10.3389/fimmu.2022.1010257] [Reference Citation Analysis]
3 Moloce MA, Costache II, Nicolae A, Onofrei Aursulesei V. Pharmacological Targets in Chronic Heart Failure with Reduced Ejection Fraction. Life (Basel) 2022;12:1112. [PMID: 35892914 DOI: 10.3390/life12081112] [Reference Citation Analysis]